Feeding Practices for Premature Infants
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two feeding methods to determine which helps premature infants reach full feeding faster. It compares bolus feeding, where nutrients are given at intervals, to continuous feeding, where nutrients are provided steadily over 24 hours. The trial focuses on preterm babies on non-invasive breathing support who are not currently eating by mouth. Parents of preterm infants born between 24 and 34 weeks, using devices like CPAP or high-flow nasal cannula for breathing, might consider this trial. As an unphased trial, it offers a unique opportunity for parents to contribute to important research that could improve feeding methods for preterm infants.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that these feeding methods are safe for premature infants?
Research has shown that both bolus and continuous feeding methods are generally safe for premature babies. Early studies suggest that bolus feeding, which involves giving nutrition in intervals, helps babies grow faster and leave the hospital sooner. Specifically, a study of very low birth weight babies found this method effective.
Continuous feeding, where nutrition is given at a steady rate, also offers benefits by providing important nutrients to premature babies. However, some reviews note that it might take longer for babies to reach full feeding levels compared to bolus feeding.
Overall, both methods are well-tolerated, with recent studies highlighting no major safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores two different feeding methods for premature infants: bolus feeding and continuous feeding. Unlike traditional feeding practices, which often vary in timing and delivery, bolus feeding provides nutrition in intervals every few hours, while continuous feeding ensures a consistent flow of nutrition over 24 hours. These methods aim to tailor nutrition according to the infant's weight and needs, potentially improving growth and health outcomes for premature babies. This trial could help determine the most effective feeding strategy, paving the way for better standard feeding protocols for these vulnerable infants.
What evidence suggests that this trial's feeding methods could be effective for premature infants?
This trial compares two methods of feeding preterm infants: bolus feeding and continuous feeding. Research has shown that both methods have advantages and disadvantages. Bolus feeding, which provides nutrition at set times, helps very low birth weight infants start feeding more effectively. Studies have demonstrated that infants fed this way reach full feeding slightly faster than those on continuous feeding. Continuous feeding delivers a steady flow of nutrition over 24 hours. Although it ensures a constant nutrient supply, it often takes longer for infants to reach full feeds compared to bolus feeding. This trial continues to study both methods to determine the best way to nourish preterm babies.23678
Who Is on the Research Team?
Rajeev Kumar, MD
Principal Investigator
Cook County Health
Are You a Good Fit for This Trial?
This trial is for preterm infants between 24-34 weeks of gestation who are not eating by mouth or only receiving minimal feeds and require non-invasive breathing support. Infants with major birth defects, those on invasive ventilation, or older than 34 weeks gestational age cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Infants are randomized to receive either continuous nasogastric feeding or intermittent bolus feeds
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Method of feeding
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rajeev Kumar
Lead Sponsor